| ★ |  Survodutide Shows Fat Mass Loss, Liver Fat Reductions in Patients With Obesity Without T2D | | 1.6K | Estados Unidos | |
| 20 |  Are GLP1’s For Everyone? Which One Is Right For You? | Talking With Docs @talkingwithdocs | 191.9K | Canadá | 88 |
| 7 |  Retatrutide Just Broke Every Obesity Record | Dr Brad Stanfield @drbradstanfield | 57.0K | Nueva Zelanda | 88 |
| 4 |  GLP-1s and Cardiovascular Risk: What the Latest Evidence Reveals | Metabolic Mind @metabolicmind | 49.3K | Estados Unidos | 89 |
| 8 |  Peptide Revolution: Healing, Fat Loss, and Longevity Without GLP-1's | Dr. G's Lifestyle Medicine Network @gooddrg | 4.1K | Estados Unidos | 88 |
| 13 |  Unlocking Weight Loss Secrets No Plateaus, Diabetes Reversed! #weightloss #retatrutide #glp1 | Dr. G's Lifestyle Medicine Network @gooddrg | 2.8K | Estados Unidos | 88 |
| 16 |  Do GLP-1s Work for Depression—or Is It Metabolism? | Metabolic Mind @metabolicmind | 2.5K | Estados Unidos | 88 |
| 6 |  Retatrutide Provides Substantial Weight Loss in Patients With Obesity or Overweight | | 1.1K | Estados Unidos | 88 |
| 11 |  GLP-1 Therapies: Where We’ve Been & Where We’re Going | Conversations on Health Care @cohcpodcast | 541 | Estados Unidos | 88 |
| 5 |  Diabetes Dialogue: Retatrutide Phase 3 Data Show Major Weight Loss | | 533 | Estados Unidos | 89 |
| 3 |  GLP-1 Medications for Weight Loss: the Latest Research | DarioHealth @dariohealthwellbeing | 365 | Estados Unidos | 89 |
| 9 |  TRIUMPH-2: Retatrutide Reduces Weight, A1C in Patients With Obesity | | 350 | Estados Unidos | 88 |
| 2 |  Berobenatide Monthly GLP-1 Injectable Shows Promise for Weight Loss | | 250 | Estados Unidos | 89 |
| 1 |  SYNCHRONIZE-1: Survodutide Achieves Significant Weight Loss Versus Placebo | | 174 | Estados Unidos | 95 |
| 12 |  Rapid Evolution in GLP-1s and Therapeutics at ADA 2026 | | 171 | Estados Unidos | 88 |
| 18 |  Retatrutide Cuts Weight, Cardiovascular Disease Risk in TRIUMPH-3 | | 158 | Estados Unidos | 88 |
| 17 |  GLP-1 Weight Loss Drugs : Miracle Cure or Costly Mistake? ( Facts vs Hype ) | Live Long and Well With Dr. Bobby @drbobbylivelongandwell | 113 | Estados Unidos | 88 |
| 14 |  ZUPREME-1: Petrelintide Reduces Obesity, Maintains Tolerability in Phase 2 Trial | | 81 | Estados Unidos | 88 |
| 19 |  Incretins, Monitors, and Insulin Titration at ADA 2026 | | 76 | Estados Unidos | 88 |
| 15 |  GLP-1 Discontinuation in Type 2 Diabetes: What Happens When Patients Stop? | | 64 | Estados Unidos | 88 |
| 10 |  #62: GLP-1s: Life-Changing Results… at What Cost? | Live Long and Well With Dr. Bobby @drbobbylivelongandwell | 56 | Estados Unidos | 88 |